• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>IMS Health

IMS Health

Cannabis Rx Inc CANA

Last Price$0.16Day Change (%)0%
Open Price$0.16Day Change ($)0.00
Day Range0.16–0.1652-Week Range0.13–7.20

As of Wed 12/24/2014 12:59 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. IMS Health Names Mason Tenaglia Vice President, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics

    IMS Health Names Mason Tenaglia Vice President, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics

  2. Mylan Launches First Generic Version of Vivelle-DOT®

    Mylan Launches First Generic Version of Vivelle-DOT®

  3. IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit

    IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit

  4. Fitch Affirms Teva's Ratings at 'BBB+'; Outlook Stable

    Fitch Affirms Teva's Ratings at 'BBB+'; Outlook Stable

  5. Cegedim: EBIT from Recurring Operations Grew in Third Quarter 2014

    Cegedim: EBIT from Recurring Operations Grew in Third Quarter 2014

  6. Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®

    Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®

  7. Our Take on the Second Quarter

    Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.

  8. Trouble in Plain Sight

    IMS Health is on the right track for growth.

  9. Our Take on the Fourth Quarter

    A look back at the winners and losers of the final quarter of a tumultuous year.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.